ADNCD
ADNCD
ANTI-DIABETIC NATURAL COMPOUNDS DATABASE
Home
Mode of Action
Browse Information
About us
Contact us
Select Mode of Action
AMPK activators
CD38 Expression Downregulators
DPP-IV Inhibitors
Enzyme Inhibitors
GLP-1 agonists
GLUT4 activators
KATP channel Inhibitors
Natural compounds for other diabetes related issues
Natural compounds improving expression of Insulin Receptor
Natural compounds improving Glucose Uptake
Natural compounds improving Insulin Secretion
Natural compounds improving Insulin Sensitivity
Natural compounds modifying the level of Akt phosphorylation
Natural compounds reducing Diabetic Nephropathy/Diabetic Neuropathy/Diabetic Cataract/Cardio-vascular Complications
Natural compounds showing Hypoglycemic activity/Anti-diabetic activity
Natural compounds showing Insulin Mimetic Activity
Natural compounds showing Insulinotrophic effect
PPAR- γ, α and δ activation
SGLT2 inhibitors
Anti-diabetic mode of action:
Insulin Mimetic Activity
Natural compounds showing Insulin Mimetic Activity
S.No.
Compound
Reference
Physicochemical Properties and Toxicity Risks
1
D-Pinitol
Kim et al., 2007
Properties and Risk Assessment
2
Strictinin
Chauhan et al., 2010
Properties and Risk Assessment
3
Isostrictinin
Chauhan et al., 2010
Properties and Risk Assessment
4
Pedunculagin
Chauhan et al., 2010
Properties and Risk Assessment
5
Kaempferol 3-neohesperidoside
Zanatta et al., 2008
Properties and Risk Assessment
6
(-)epicatechin
Rizvi and Zaid, 2001
Properties and Risk Assessment